Barriers to Buprenorphine Prescribing Among Attending Physicians in an Academic Residency Program - Implications for Increased Buprenorphine Usage.  van Deventer E, Antonson D, Soske J, Geary M, Vanjani R.  R I Med J (2013). 2023 Oct 2;106…

What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities.  Ackland PE, Kenny ME, Clothier BA, Salameh HA, Boening N, Gordon AJ, Noorbaloochi S, Gustavson AM, Miller W, Hagedorn H…

Reisen mit Betäubungsmitteln BOPS. Reisen mit Betäubungsmitteln Nach den Bestimmungen der Betäubungsmittel-Verschreibungsverordnung (BtMVV) darf ein Arzt für Patienten Betäubungsmittel in angemessener Menge verschreiben. Der Patient darf die aufgrun…

Griechenland. Closure of harm reduction units in Greece: Austerity politics trumping community empowerment? The recent decision by OKANA, the Greek government’s agency for drug services, to close seven harm reduction units, including one in Goudi (A…

Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings: Two Randomized Clinical Trials.  Sigmon SC, Peck KR, Batchelder SR, Badger GJ, Heil SH, Higgins ST.  JAMA Netw Open. 2023 Sep 5;6(9):e2331910. doi: 10.1001/jamanet…

Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring - a focus on the Italian system.  Mannaioni G, Lugoboni F.  Drugs Context. 2023 Aug 24;12:202…